Keywords: Type 1 diabetes; Children; Treatment; Glycemic control; HbA1c;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Clinical inertia; HbA1c; Oral glucose-lowering medication; Pharmacoepidemiology; Treatment intensification; Type 2 diabetes; Diabète de type 2; HbA1c; Inertie thérapeutique; Intensification du traitement; Médicaments hypoglycémiants oraux; Pharmaco-é
Keywords: Prediabetes; hyperfiltration; glomerular filtration rate (GFR); albuminuria; iohexol clearance; measured GFR; estimated GFR; fasting glucose; HbA1c; albumin-creatinine ratio (ACR); chronic hyperglycemia; renal disease; modifiable risk factor; Tromsø stud
Keywords: ABCA1; ATP-binding cassette transporter 1; ABCG1; ATP Binding Cassette G1; AMPK; 5â²AMP-activated protein kinase; AP-1; activator protein 1; apo A-I; apolipoproteins A-I; AT; adipose tissue; CCK-1; cholecystokinin; CD; Crohn's disease; CVD; cardiovascula
Keywords: Glycaemic control; HbA1c; Type 2 diabetes; Public health clinic; Johor;
Keywords: ACS; acute coronary syndrome; AECOPD; acute exacerbation of Chronic Obstructive Pulmonary Disease; AF; atrial fibrillation; APACHE; acute physiology and chronic health evaluation; BMI; body mass index; BODE; BMI, obstruction, dyspnea, exercise capacity; C
Keywords: Type-1 diabetes; Adults; Diabetes distress; Emotional burden; Social support; Generic quality of life; Diabetes empowerment; Self-management; HbA1c;
Keywords: BMI; body mass index; CHD; coronary heart disease; HbA1c; glycated hemoglobin; HR; hazard ratio; MEC; mobile examination center; NHANES; National Health and Nutrition Examination Survey;
Keywords: Type 2 diabetes; Meta-analysis; Depression; Self-efficacy; Explanatory models; HbA1c
Keywords: Palm tocotrienols; Palm carotenes; Vascular function; Flow-mediated dilation; AI; augmentation index; BMI; body mass index; CTAB; citrate, theophylline, adenosine and dipyridamole; CV; coefficient of variance; CVD; cardiovascular disease; EFSA; European F
Keywords: BMI; body mass index; CB; common buckwheat; DC; diet control; HbA1c; glycated hemoglobin; HDL-c; high-density lipoprotein cholesterol; HOMA-IR; homeostasis model assessment of insulin resistance; LDL-c; low-density lipoprotein cholesterol; MetS; metabolic
Keywords: AGES-RS; Age, Gene/Environment Susceptibility-Reykjavik Study; BMI; body mass index; CI; confidence interval; CVD; cardiovascular disease; CWS; cotton wool spots; HbA1c; hemoglobin A1c; HDL; high-density lipoprotein; HEM; dot or blot hemorrhage; HR; hazar
Keywords: cardiovascular disease; obesity; pharmacology; prevention; risk factors; BMI; body mass index; FDA; Food and Drug Administration; GLP; glucagon-like peptide; HbA1c; glycosylated hemoglobin; HDL-C; high-density lipoprotein cholesterol; HR; hazard ratio; h
Keywords: CRP; C-reactive protein; DXA; dual-energy X-ray absorptiometry; HbA1c; hemoglobin A1c; HDL-C; high-density lipoprotein cholesterol; HEI; Healthy Eating Index; HOMA; homeostasis model assessment; HR; hazard ratio; LDL-C; low-density lipoprotein cholesterol
Keywords: AUC; Area under the curve; BMI; Body mass index; CGM; Continuous glucose monitoring; CRP; C-reactive protein; HbA1c; Hemoglobin A1c; HDL-C; High density lipoprotein-cholesterol; ICAM-1; Intercellular adhesion molecule 1; iHOMA2; Interactive homeostatic mo
Keywords: BMI; body mass index; FITTER; Forum for Injection Technique and Therapy: Expert Recommendations; HbA1c; glycated hemoglobin; IM; intramuscular; ITQ; Injection Technique Questionnaire; LH; lipohypertrophy; NPH; neutral protamine Hagedorn (also known as ins
Keywords: diastolic pressure gradient; heart failure with preserved ejection fraction; heart failure with reduced ejection fraction; isolated post-capillary pulmonary hypertension; pulmonary arterial hypertension; CI; confidence interval; Cpc-PH; combined post-capi
Keywords: Schizophrenia; Clozapine; Metabolic syndrome; Treatment; Meta-analysis; BMI; Body mass index; CHAOS; Coronary artery disease, hypertension, atherosclerosis, obesity, and stroke; HbA1c; Glycosylated haemoglobin; HDL; High-density lipoprotein; Kg; kilogram;
Keywords: canagliflozin; diabetes; glycemic control; HbA1c; Medicare; SGLT2 inhibitors;
Keywords: hypogonadism; testosterone; energy; libido; AE; adverse event; BMI; body mass index; CV; cardiovascular; HbA1c; hemoglobin A1c; HED; Hypogonadism Energy Diary; I-PSS; International Prostate Symptom Score; LC-MS/MS; liquid chromatography tandem mass spect
Keywords: Noninvasive indices; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Simple steatosis; Treatment; ABCA1; ATP-binding cassette transporter subfamily A, member A1; ALT; alanine transaminase; AST; aspartate transaminase; AMPK; 5â² adenosine
Keywords: BGL/s; blood glucose level/s; BMI; Body Mass Index; CER; continuous energy restriction; CSIRO; Commonwealth Scientific and Industrial Research Organisation; ER; energy restriction; FFM; fat-free mass; FM; fat mass; FPG; fasting plasma glucose; HbA1c; glyc
Keywords: Diabetes; Glycemia; HbA1c; Glycated albumin.;
Keywords: DM; diabetes mellitus; RCTs; randomized controlled trials; CBM; Chinese Biomedical Literature database; FBG; fasting blood glucose; 2hBG; postprandial 2h blood glucose; HbA1c; glycosylated hemoglobin; TG; triglyceride; TC; total cholesterol; LDL-c; low de
Keywords: chest imaging; diabetes; global medicine; tuberculosis; DM; diabetes mellitus; DOTS; directly observed therapy, short course; EDOTS; Effects of Diabetes on Tuberculosis Severity Study; FPG; fasting plasma glucose; HbA1c; hemoglobin A1c, or glycohemoglobin
Keywords: Glycemic control; Hypoglycemia; HbA1c; Fracture; Diabetes; Geriatric;
Keywords: BiP; binding of immunoglobulin protein; BMI; body mass index; CHOP; CCAAT/enhancer-binding protein homologous protein; C-peptide; insulin connecting peptide; ER; endoplasmic reticulum; FPIR; first phase insulin response; GAD65; glutamic acid decarboxylase
Keywords: DPP-4; GLP-1; Treatment; Vomiting; CI; confidence interval; DCCT; Diabetes Control and Complications Trial; DPP; dipeptidylpeptidase; EDIC; Epidemiology of Diabetes Intensive Complications; GE; gastric emptying; GI; gastrointestinal; GIP; glucose-dependen
Keywords: Resveratrol (PubChem CID: 445154); ALT; alanine amino-transferase; AST; aspartate amino-transferase; BMI; body mass index; CRP; C-reactive proteins; EPIC; European Prospective Investigation into Cancer and Nutrition; HbA1c; glycated hemoglobin; GGT; ɣ-gl
Keywords: Biomarker; Diabetes; Metabolomics; Glucose; Predictive modeling; ANOVA; analysis of variance; AUC; area under the receiver operating characteristic curve; BMI; body mass index; BRC; Bavarian Red Cross Blood Transfusion Center study; ELISA; enzyme-linked i
Keywords: Glycated albumin; HbA1c; Albumin; Acromegaly; Growth hormone;
Keywords: Dipeptidyl peptidase-4 (DPP-4) inhibitor; Sitagliptin; Creatinine; HbA1c;
Keywords: BMI; Body mass index; HbA1c; Hemoglobin A1c; HDL-C; High-density lipoprotein cholesterol; LDL-C; Low-density lipoprotein cholesterol; non-HDL-C; Non-high-density lipoprotein cholesterol; T1D; Type 1 diabetes;
Keywords: Diabetic nephropathy; Glycated albumin; HbA1c; End-stage renal disease; Glycemic excursion
Keywords: Type 2 diabetes mellitus; Somatic neuropathy; BMI; HbA1c; Complications;
Keywords: Glycated albumin; HbA1c; Type 2 diabetes mellitus; Body mass index; Insulin secretion;
Keywords: BMI; Body mass index; HbA1c; Hemoglobin A1c; PDC; Pediatric Diabetes Consortium; T1D; Type 1 diabetes;
Keywords: BMI; Body mass index; GDM; Gestational diabetes mellitus; HbA1c; Glycated hemoglobin; REE; Resting energy expenditure;
Keywords: Personality; Polygenic risk; Type 2 diabetes; Gene-trait interaction; HbA1c; Cognitive ability; Conscientiousness; Agreeableness; Openness;
Keywords: Hemoglobin A; Glycated; HbA1c; Pre-diabetes; Coronary artery disease; Myocardial infarction; Mortality;
Keywords: Nutrition-related risk indexes; Parenteral nutrition; Long-term mortality; Noncritically ill inpatients; Spain; CRP; C-reactive protein; GNRI; geriatric nutritional risk index; HbA1c; glycated hemoglobin; NRI; nutritional risk index; SGA; subjective globa
Keywords: ADA; American Diabetic Association; BMI; body mass index; BP; blood pressure; CT2DM; clinical type 2 diabetes mellitus; DCCT; Diabetes Control and Complications Trial; DM; diabetes mellitus; EDTA; ethylenediamine tetra acetic acid; GAD; glutamic acid deca
Keywords: RPON; recurrent painless ophthalmoplegic neuropathy; VAS; visual analog scale; MRI; magnetic resonance imaging; NSAI; non-steroidal anti-inflammatory; PTZ-INR; partial thrombin time-International normalized ratio; aPTT; activated partial thrombin time
Keywords: Fructosamine; Cardiovascular mortality; All-cause mortality; Risk factor; Prospective studyBMI, body mass index; CHD, coronary heart disease; CI, confidence interval; CRP, C-reactive protein; CVD, cardiovascular disease; FPG, fasting plasma glucose; HbA1c
Keywords: Pediatric; Diabetes; Insulin pump; HbA1c
Keywords: Screening; HbA1c; Primary prevention; Short messaging serviceBMI, body mass index; FBG, fasting blood glucose; GTT, glucose tolerance test; HbA1c, glycated hemoglobin; IDF, International Diabetes Federation; IFG, impaired fasting glucose; IGT, impaired gl
Keywords: AIRg; Acute insulin response to glucose; BMI; Body mass index; DI; Disposition index; DM; Diabetes mellitus; HbA1c; Hemoglobin A1c; HOMA; Homeostatic model assessment; HOMA-IR; Homeostatic model assessment of insulin resistance; NGT; Normal glucose tolera
Keywords: HbA1c; MEMS; Microfluidic; Diabetes mellitus; Aptamer;
Keywords: ABI; ankle-brachial index; ADMA; asymmetric dimethylarginine; CI; confidence interval; CV; coefficient of variation; EDTA; ethylene diamine tetra-acetic acid; eGFR; estimated glomerular filtration rate; HbA1c; glycated hemoglobin; HDL; high-density lipo
Keywords: Glycaemic variability; HbA1c; Hypoglycaemia; Type 2 diabetes mellitus; Treatment intensification